pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-16-2 |
Genomic Coordinates | chr3: 160404745 - 160404825 |
Description | Homo sapiens miR-16-2 stem-loop |
Comment | This entry represents a second putative hairpin precursor sequence for miR-16, located on chromosome 3 (see also MIR:MI0000070). The sequence was previously named mir-16-3 here and in references . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-16-2-3p | ||||||||||||||||||
Sequence | 53| CCAAUAUUACUGUGCUGCUUUA |74 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | KLHL15 | ||||||||||||||||||||
Synonyms | HEL-S-305 | ||||||||||||||||||||
Description | kelch like family member 15 | ||||||||||||||||||||
Transcript | NM_030624 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on KLHL15 | |||||||||||||||||||||
3'UTR of KLHL15 (miRNA target sites are highlighted) |
>KLHL15|NM_030624|3'UTR 1 TGACATCCTCCTCCCTAAAAAAAGAGGCAAACAAAGTATTTGTTTGCACAGAGTAATTAATTAAAACATATAAAGAAAAA 81 CCTCACCAGTTTTACTATCAAAGCCATTGGTCTAACATTGTAAGAATTTTTCATTCTGTGCTAGCATCCTTTTTTTCTTT 161 TCAGTGGCCTCAAACTCATGCAATAAGTTAATTCTAAGTGCTAGCTCTTGAAACTACTTCCAGAAGCAGTTGAATAGAAT 241 GCTCCACTTATCTGGGATATTGATTTTCTGCTTTAAACATTTCTTTCAGATGTTAGCGTAGGAGTCATGTGTCTTCTAAG 321 AGAAGACCCGATAAGTGTCACTGGATGTGATTTCAGTCTCTGTCTCTATCTGAAACCTTTTTGAAGATTTATTTCAGTGT 401 ATTTCAGTCTGTTATACTTTTTAGTTTTATTATTTAAAAGTTTAAAACTCTTGACCTTTTTGCATGGCTTTTTGCTGAAA 481 ATGCAAAAATATAAATTTTCTACAAAATTAACTTTTTATATTCAAAACACTATTTCTAAGCTGCCTTCTCTTATCCGCAT 561 TGTGTTAGTGAAAGCATATTCATACTCGCATACAACCTATAAATACACAAGGCACATCCCTTTTATGCGTGGTTAGGATT 641 CTATATTTTTAAGCTAGTGCACTTACTTGCACACACAGTTCGCCATACTTGTTGAATTTTAGATGTAACGTCTTTTCACA 721 TATTAACATTTTTAGAAAGTTGAAATAACTGGAGTCCTCATTTGCTATCAAAGTAGCCTATCTTCAGTCCATACTGATTC 801 AGTAATATTTGAACTCCTTATATTTCTGAAACATGTATGGTTATGAAAACTAACACTTTATATTTTATTTTCAAAAGTAA 881 ATGTTAGTGTTCTTTGTCGATGTATGTCTTTTCTTTTTGAAAATGTTTTTCTTTGCAGTCTGTTTAACGTTACCCTGTTT 961 TTAGTGAGAATCGGAGTGGTATATGACAAGTTCTGGCCCTGCAGCATGCAAGCACTTTTAAAGAGCATTTAGGTAATACC 1041 AGACTCCTAAATCAAGGCCCCTTAAAAGTAAGTGCAACTCCCATTTTTTACATTCAGTAAGGCTGCTGCATTTGTTATTG 1121 AATGGAAGGTAGAAACTCTTAGAAAATTTGACCTCAGTTTTGACTTAGAGGTAAGAAATAGAATTATAATGTTACTGGTT 1201 TTATCTACTTGTTTATTTTGTACAAAATACCCAGCGACACTAGGGATGTAAGCCCTCAGTTTTTGTTTTATTTACTGAAA 1281 GCTATTAGCATGAAGGATAGTAACCACAAAGTTCAGAATGGATCAAGAATAGCTGTTTAAAAGCATTTATAATAAGTGTT 1361 TTAGGATTAGCTGCACCTTTCAACTCTTTAAATGCAGAGGAAAAAACATAGTTGACAAAGTTAAGCAAGAATAACCTGGG 1441 AGTGGATCATTGAAATTGATGCCATTTGCGCATGAGTAGTCTATATCTGATACAGACTAGATCTATACTGGCAAAACTTG 1521 CCAGATCTTAGAATATTGGTGCAATATTGCAATGCCTTCTATATGGCTGCTGATGTATAAATTTTCTAGTTTCACTTTGT 1601 TTGGTGTTTTTTGTTTTTTTGTTTGTTTGTTTGTTTTTTTGCTGCTGCCACCATTGAACATAAAATGGAAGTGTGAAGTC 1681 ATGGAAATGTGAAGACTTTGGTTTTTGGGGGTTTTTTGGGCAGTTATTAGACATACTATGAGATTAAACCTGATCTTCAA 1761 ACTCCAGAATTGGAGGCATTTGGGTTTAAGAAACCAGGTACATAAGTAGCTTTTGAAAAAACCATTGGCATTGATTTCAA 1841 AAATCAATAATAATCTTATTTTATATATGAGACTTATATTTTCATTAACTAGTCCTGTCATTTACTTACAGTTTCCAAAC 1921 ATGAAATTTGGTATCTTGTTTCCCATGGTAATATGGGTAAAAGTCTTTTTCTACATTTAAAAAATACATTATTTTATTTT 2001 TGAAAGTTAGGAATAAGTTAGCCATTTAATTTTTTTCTACATTAGTTTAGTGGCTTTGTATGTGTGCTATTTTGCTTTAA 2081 AGAAAATAACGTCTTCATTATTTTCCTCATTGATGTCTTTTGCTAGAAAAGACCAAGAAAGAGCCATCAGGCCAGGTATC 2161 CACATCAAAGCCTTTACACTATAGTGGTGGTTCTCTTTAATTGCTTAGATATGACTTCATGACCCTAGTCAGGGTGACAT 2241 CTGGGCAAACATTTGAGTATTCTTGGTCTTCCATTTTAAAGACAGAGGCCAAGATCAAAGTTCATGTTTTGTAAAATTCG 2321 TAAAATCTTAACTTGAACTAACTCTGGGTTCAGCTTTACGTAAGTCACGTCGGACCTGATGTTAGCTGTAATCAGTTTTG 2401 AGCTTTAAGGATAGTTGCTGTTGCTTGGGTTCTGAATGTATGAGAAAACTCCCTGTTTATATGTAGTTCTAATTTAGGTT 2481 ATTTTAAATCCATGATTAACTTACATTCCCTTTTAAAATTATGGTTTTATTGCTGCAAGAGATTTATTTTTGTTATACTA 2561 AACTATGGAAAAGTTTTTCATAGCATTTTTTTCAAGTTTATTTTTTGTGTGCTTCATTTGGAGTTTTTGTTTATATACAT 2641 TGCGCTCAAAAAAGTAGTTTTTTGAAAAATTCAGTAAGATTTGAATCTATACAGTTTAACTGTTATGACCTTTATGCGTG 2721 TTGTTTTCACTTTATATCTCAAATGCCAGAGTTCACAAAAATAGCTGATCTTCATTAATTACATCTTAATTAGAACCATT 2801 TGTTCTCTTCCGTGTCTTTGACCTTCTAAGTTTTGATTTTAAAGAAATTCCTTGCACTACAGCCTTTTCTTAAAATGCAA 2881 GATTCTCACTTTGAAGGTTTTGTGTTGGAAGAAATGCTACTGGTTTTTAAAAAGCAAAGCTTAACTAATAGAATTATTAG 2961 CTTTTCTTGAGACAGCTTTCTGTGTCCTCATTACTCTGCTCTGTGTGAGTGTTACTAGAATTTGTGAAATACTGACTGAG 3041 CCCTTCACTTATCTTTTCTAAAGCAGCACCTTTGGACACCTCATTCTGGGAAGCCTGCTCGAGTCATAGTAAAGGACACA 3121 CGCTTTATGTGGGGAGAAGTGGTAAAAATGGAGTTTTGTCTTAATTACATGAAACTAAGCTTTAAAATATTTTATAACAG 3201 ATTATTTGAGCTGCATAATCTAAACATGTCAAACGTTCAGTGGGACTATTTTTATATATGTATATGTGGGTGTAGGTCAT 3281 AACATTTCAGTTTATAATATAAATTGTTATTTCAGTTTATAAGCTATCTCTCAGAGGAGACTAGCTCTTTTGAGAATTCA 3361 TAATTTAAAGTTTTAGACTGAAGTAAAATGCAACATAGATAATAGTGTAAATCAGATATAATTGAGGGCTATATGGCAGT 3441 AAAACTGCTAGTGCCAGTTTTCTTGTTTGCCTGTTATACATTTTTGATTTTTGTTTTTGTATTCTGAACATTTTGAGAGA 3521 TCATATGTTTGTTCAATTACATTTAGAGTTGGTTTGGGAATAAATATCTTCTAAAAAGAGATTTATCTTAAAAATGGAAG 3601 TCCTAAAAATTAGTTTATCCAGAGTTTATAAAGTCAAATATTCAGTAGGCATAGACTGGAATAGATAAATTCATGGAAAT 3681 CATATCCTTTCAGTACACCGTATAACTTCAATATTACACAAGTAACATTGAGGAGAATGCCATCAGCTTTGTTCTCCCTT 3761 AAATTCTTTGGTTTTCTTTTTACATTTTGGGAACAACTGCATTTAAAATGTTATTAGTCAGTATATAGTAAGGATTAGGT 3841 GTTTGCTTTCTGAAGGAATGGTCCAGTGAGGTGATTGGGAGAGGTTATTTTCTACCTAACTTGTATATGCCCTATACCTC 3921 TTGGGCATACTTTGTCTATAGAAAAATATTTTGACCTTTAGGTACATTTTGGGCCAGTAGTCAAATAATCCTAGGGCCGA 4001 TATAAAAATCTTAGAATAATTTAAGGTTTGCCTTTTATACCTGTTTTGAAAGCCTTTACATTTTTGTCAGGTAATTTTTC 4081 CCAAGCCGTGGATATAATCTATTCAAACATGTTTATGCTATCCATTCTGTTTTTAAATTGAAAAAAATGTTAAAAGTGTT 4161 TATGAAGAAAAGTTTAAATAAAATATTTTTAATCTTTAAAATATAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 80311.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
"PAR-CLIP data was present in GSM714646. RNA binding protein: AGO2. Condition:mildMNase
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 80311.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000328046.8 | 3UTR | AAUAUUGGUGCAAUAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000328046.8 | 3UTR | AAUAUUGGUGCAAUAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000328046.8 | 3UTR | AUUUUCUGCUUUAAACAUUUCUUUCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000328046.8 | 3UTR | AUCUAUACUGGCAAAACUUGCCAGAUCUUAGAAUAUUGGUGCAAUAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM714646 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / mildMNase, repA |
Location of target site | ENST00000328046.8 | 3UTR | AGAUCUUAGAAUAUUGGUGCAAUAUUGCAAUGCCUUCUAUAUGGCUGCUGAUGUAUAAAUUUUCUAGUUUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000328046.8 | 3UTR | AAUAUUGGUGCAAUAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000328046.8 | 3UTR | AUCUAUACUGGCAAAACUUGCCAGAUCUUAGAAUAUUGGUGCAAUAUUGCAAUGCCUUCUAUAUGGCUGCUGAUGUAUAAAUUUUCUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
75 hsa-miR-16-2-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT004488 | RARB | retinoic acid receptor beta | 3 | 1 | ||||||||
MIRT038707 | NUCKS1 | nuclear casein kinase and cyclin dependent kinase substrate 1 | 1 | 1 | ||||||||
MIRT057208 | PPIF | peptidylprolyl isomerase F | 2 | 4 | ||||||||
MIRT058726 | RSBN1 | round spermatid basic protein 1 | 2 | 8 | ||||||||
MIRT074502 | NFATC2IP | nuclear factor of activated T-cells 2 interacting protein | 2 | 4 | ||||||||
MIRT081544 | ZNF431 | zinc finger protein 431 | 2 | 4 | ||||||||
MIRT096893 | ERBB2IP | erbb2 interacting protein | 2 | 2 | ||||||||
MIRT105124 | MYC | MYC proto-oncogene, bHLH transcription factor | 2 | 2 | ||||||||
MIRT107898 | PTAR1 | protein prenyltransferase alpha subunit repeat containing 1 | 2 | 4 | ||||||||
MIRT109432 | KLHL15 | kelch like family member 15 | 2 | 6 | ||||||||
MIRT166742 | PAPD7 | poly(A) RNA polymerase D7, non-canonical | 2 | 6 | ||||||||
MIRT171257 | YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma | 2 | 2 | ||||||||
MIRT192760 | B2M | beta-2-microglobulin | 2 | 2 | ||||||||
MIRT194905 | RBBP6 | RB binding protein 6, ubiquitin ligase | 2 | 8 | ||||||||
MIRT215599 | SUB1 | SUB1 homolog, transcriptional regulator | 2 | 2 | ||||||||
MIRT223632 | ATP6V1C1 | ATPase H+ transporting V1 subunit C1 | 2 | 4 | ||||||||
MIRT241605 | AMOTL1 | angiomotin like 1 | 2 | 4 | ||||||||
MIRT291174 | SH3GLB1 | SH3 domain containing GRB2 like, endophilin B1 | 2 | 2 | ||||||||
MIRT444286 | ABCG2 | ATP binding cassette subfamily G member 2 (Junior blood group) | 2 | 2 | ||||||||
MIRT463285 | ZFX | zinc finger protein, X-linked | 2 | 4 | ||||||||
MIRT471759 | NUS1 | NUS1 dehydrodolichyl diphosphate synthase subunit | 2 | 8 | ||||||||
MIRT479611 | CDC25A | cell division cycle 25A | 2 | 2 | ||||||||
MIRT481497 | ARL6IP1 | ADP ribosylation factor like GTPase 6 interacting protein 1 | 2 | 8 | ||||||||
MIRT483117 | SH3BP5 | SH3 domain binding protein 5 | 2 | 2 | ||||||||
MIRT502279 | GRPEL2 | GrpE like 2, mitochondrial | 2 | 8 | ||||||||
MIRT507838 | CCNT1 | cyclin T1 | 2 | 2 | ||||||||
MIRT508179 | MTRNR2L6 | MT-RNR2-like 6 | 2 | 4 | ||||||||
MIRT510576 | UBE2D3 | ubiquitin conjugating enzyme E2 D3 | 2 | 6 | ||||||||
MIRT517853 | RPS4X | ribosomal protein S4, X-linked | 2 | 4 | ||||||||
MIRT521690 | PRKAA1 | protein kinase AMP-activated catalytic subunit alpha 1 | 2 | 8 | ||||||||
MIRT525070 | FRK | fyn related Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT527082 | UBE2E3 | ubiquitin conjugating enzyme E2 E3 | 2 | 2 | ||||||||
MIRT529552 | EI24 | EI24, autophagy associated transmembrane protein | 2 | 2 | ||||||||
MIRT530426 | SULT1B1 | sulfotransferase family 1B member 1 | 2 | 2 | ||||||||
MIRT533909 | TBC1D15 | TBC1 domain family member 15 | 2 | 2 | ||||||||
MIRT536627 | IPO7 | importin 7 | 2 | 2 | ||||||||
MIRT537647 | ERGIC2 | ERGIC and golgi 2 | 2 | 4 | ||||||||
MIRT538512 | CLCN3 | chloride voltage-gated channel 3 | 2 | 2 | ||||||||
MIRT539219 | ANP32E | acidic nuclear phosphoprotein 32 family member E | 2 | 6 | ||||||||
MIRT539348 | AGO2 | argonaute 2, RISC catalytic component | 2 | 4 | ||||||||
MIRT539954 | CCT4 | chaperonin containing TCP1 subunit 4 | 2 | 2 | ||||||||
MIRT541208 | HOXA10 | homeobox A10 | 2 | 2 | ||||||||
MIRT543216 | TMEM117 | transmembrane protein 117 | 2 | 2 | ||||||||
MIRT543399 | DROSHA | drosha ribonuclease III | 2 | 2 | ||||||||
MIRT546648 | RPS6KA5 | ribosomal protein S6 kinase A5 | 2 | 2 | ||||||||
MIRT546852 | RAB1A | RAB1A, member RAS oncogene family | 2 | 2 | ||||||||
MIRT549917 | MRPS30 | mitochondrial ribosomal protein S30 | 2 | 2 | ||||||||
MIRT552998 | USP46 | ubiquitin specific peptidase 46 | 2 | 2 | ||||||||
MIRT555254 | PREPL | prolyl endopeptidase-like | 2 | 2 | ||||||||
MIRT555956 | NRIP1 | nuclear receptor interacting protein 1 | 2 | 2 | ||||||||
MIRT557095 | HOXA9 | homeobox A9 | 2 | 2 | ||||||||
MIRT561396 | TUBB2A | tubulin beta 2A class IIa | 2 | 2 | ||||||||
MIRT561654 | RNF219 | ring finger protein 219 | 2 | 2 | ||||||||
MIRT563101 | PABPC4L | poly(A) binding protein cytoplasmic 4 like | 2 | 2 | ||||||||
MIRT565979 | RNF44 | ring finger protein 44 | 2 | 2 | ||||||||
MIRT572396 | CCDC14 | coiled-coil domain containing 14 | 2 | 2 | ||||||||
MIRT574400 | TM9SF3 | transmembrane 9 superfamily member 3 | 2 | 2 | ||||||||
MIRT607623 | VSNL1 | visinin like 1 | 2 | 2 | ||||||||
MIRT610645 | CTGF | connective tissue growth factor | 2 | 2 | ||||||||
MIRT623379 | LPP | LIM domain containing preferred translocation partner in lipoma | 2 | 2 | ||||||||
MIRT624687 | AR | androgen receptor | 2 | 2 | ||||||||
MIRT632089 | ALDH1A2 | aldehyde dehydrogenase 1 family member A2 | 2 | 2 | ||||||||
MIRT644216 | CBS | cystathionine-beta-synthase | 2 | 2 | ||||||||
MIRT647841 | BID | BH3 interacting domain death agonist | 2 | 2 | ||||||||
MIRT651649 | WASF2 | WAS protein family member 2 | 2 | 2 | ||||||||
MIRT689064 | AGMAT | agmatinase | 2 | 2 | ||||||||
MIRT698150 | TNPO1 | transportin 1 | 2 | 2 | ||||||||
MIRT700516 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 2 | 2 | ||||||||
MIRT704081 | DYRK2 | dual specificity tyrosine phosphorylation regulated kinase 2 | 2 | 2 | ||||||||
MIRT705970 | ACBD5 | acyl-CoA binding domain containing 5 | 2 | 2 | ||||||||
MIRT715694 | COMMD3-BMI1 | COMMD3-BMI1 readthrough | 2 | 2 | ||||||||
MIRT717184 | BMI1 | BMI1 proto-oncogene, polycomb ring finger | 2 | 2 | ||||||||
MIRT724607 | AP3B1 | adaptor related protein complex 3 beta 1 subunit | 2 | 2 | ||||||||
MIRT724854 | IGFBP5 | insulin like growth factor binding protein 5 | 2 | 2 | ||||||||
MIRT725401 | LRIG2 | leucine rich repeats and immunoglobulin like domains 2 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|